In addition, Webb and colleagues [58], by using an IRIDESCENT algorithm analysis, revealed that ASC is sensitive to MECP2 activity and, moreover, transcriptional silencing of ASC gene, associated with the complete methylation of its promoter region, was observed in prostate cancer [59]. The gene discussed is MECP2; the disease is prostate carcinoma.